Ebola vaccine efficacy trial suggest vaccine provides high protection against disease

Tests of the experimental Ebola vaccine VSV-ZEBOV in over 7500 participants in Guinea suggest that the vaccine provides high protection against the disease as early as ten days after vaccination, in adults who have potentially been exposed to the virus by coming in close contact with a recently infected person. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail